One of the four defendant Chinese companies has filed a proposed settlement in U.S. District Court in Brooklyn to resolve In re: Vitamin C Antitrust Litigation. The lawsuit, brought by commercial buyers of vitamin C, alleges that the companies formed a cartel to raise prices by limiting exports. The settlement calls for Aland Nutraceutical Co. (formerly Jiangsu Jiangshuan) to pay $9.5 million to direct purchasers, and $1 million to indirect purchasers.
Judge Brian Cogan had rejected the companies’ defense that the Chinese government required price coordination in September.
Full content: Reuters
Related content: Public Vs. Private Enforcement of Antitrust Law: A Survey
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Canadian School Boards Sue Social Media Giants for $4 Billion
Mar 28, 2024 by
CPI
Alaska Airlines and Hawaiian Airlines Enter Timing Agreement with DOJ
Mar 28, 2024 by
CPI
Sam Bankman-Fried Gets 25-Year Sentence for $8B Crypto Fraud
Mar 28, 2024 by
CPI
Walmart Withdraws and Refiles Antitrust Review Application for Vizio Acquisition
Mar 28, 2024 by
CPI
Apple Prevails in Dismissal of Crypto-Payment Antitrust Lawsuit
Mar 27, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Real Estate & Antitrust
Mar 27, 2024 by
CPI
Systematic National Evidence of Steering by Real Estate Agents
Mar 27, 2024 by
CPI
Compliance Now! Actionable Antitrust Advice for the Residential Real Estate Industry
Mar 27, 2024 by
CPI
Real Estate Commissions: Some Insights from the Economics of Multi-Sided Platforms
Mar 27, 2024 by
CPI
New Ideas for Promoting Real Estate Brokerage Price Competition
Mar 27, 2024 by
CPI